Success Metrics

Clinical Success Rate
85.7%

Based on 12 completed trials

Completion Rate
86%(12/14)
Active Trials
3(15%)
Results Posted
33%(4 trials)
Terminated
2(10%)

Phase Distribution

Ph phase_4
7
35%
Ph phase_3
2
10%
Ph not_applicable
4
20%
Ph phase_2
1
5%
Ph phase_1
1
5%

Phase Distribution

1

Early Stage

1

Mid Stage

9

Late Stage

Phase Distribution15 total trials
Phase 1Safety & dosage
1(6.7%)
Phase 2Efficacy & side effects
1(6.7%)
Phase 3Large-scale testing
2(13.3%)
Phase 4Post-market surveillance
7(46.7%)
N/ANon-phased studies
4(26.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

85.7%

12 of 14 finished

Non-Completion Rate

14.3%

2 ended early

Currently Active

3

trials recruiting

Total Trials

20

all time

Status Distribution
Active(3)
Completed(12)
Terminated(2)
Other(3)

Detailed Status

Completed12
unknown3
Active, not recruiting3
Terminated2

Development Timeline

Analytics

Development Status

Total Trials
20
Active
3
Success Rate
85.7%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (6.7%)
Phase 21 (6.7%)
Phase 32 (13.3%)
Phase 47 (46.7%)
N/A4 (26.7%)

Trials by Status

completed1260%
unknown315%
terminated210%
active_not_recruiting315%

Recent Activity

Clinical Trials (20)

Showing 20 of 20 trials
NCT06049797

A Study Following Women in Menopause Treated With a Non-hormonal Therapy for Hot Flashes and Night Sweats

Active Not Recruiting
NCT07385755Not Applicable

Desvenlafaxine for Preventive Treatment of Frequent Migraines

Active Not Recruiting
NCT07359248Not Applicable

Desvenlafaxine for Preventive Treatment of Frequent Episodic Tension-type Headache

Active Not Recruiting
NCT04446039

Non-interventional, Retrospective Cohort Study to Explore Antidepressant Treatment in Korea

Completed
NCT02893371

Longitudinal Comparative Effectiveness of Bipolar Disorder Therapies

Terminated
NCT04476030Phase 3

A Comparative Study of Sage-217 Plus an Antidepressant (ADT) Versus Placebo Plus an ADT in Adults With Major Depressive Disorder

Completed
NCT04448431Phase 4

Comparison of Vortioxetine and Desvenlafaxine in Adult Patients Suffering From Depression

Completed
NCT02859103Phase 4

Dimensional Approach to Evaluate Reward Processing in Major Depressive Disorder Pre- and Post-Desvenlafaxine Treatment

Completed
NCT01975480Phase 4

Efficacy of SNRI Treatment on Prefrontality in Patients With GAD and Other Comorbities

Completed
NCT02200406Phase 4

Desvenlafaxine in Opioid-Dependent Patients

Completed
NCT03432221

Switching From SSRI to Desvenlafaxine on Cognitive Functioning

Unknown
NCT01803711Phase 2

Omega 3 FA Supplements as Augmentation in the Treatment of Depression

Terminated
NCT01537068Phase 4

Desvenlafaxine vs. Placebo Treatment of Chronic Depression

Completed
NCT02320240

Serotonin-norepinephrine Reuptake Inhibitors and Acute Kidney Injury

Completed
NCT01468610Not Applicable

Neurocognition and Work Productivity in Major Depressive Disorder (MDD)

Completed
NCT01527786Phase 3

Functional Outcome in Postpartum Depression in Women Treated With Desvenlafaxine

Completed
NCT02330679Phase 4

Prediction of Antidepressant Treatment Response Using Machine Learning Classification Analysis

Unknown
NCT01948895Not Applicable

Desvenlafaxine Monotherapy in Dysthymia

Completed
NCT01443208Phase 1

Pharmacokinetics and Safety of Desvenlafaxine in Korean Healthy Subjects Following Single and Multiple Oral Doses of Desvenlafaxine Succinate Sustained Release Tablet

Completed
NCT01492621Phase 4

Effect of Antidepressants on White Matter Structure

Unknown

All 20 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
20